Consultation hotline：
中文 | English
Your location: Home page >News and information >
source:　time:
Cothera Bioscience has announced that the NMPA has approved a Phase II clinical trial of PC-002 for high-grade B-cell lymphoma
Cothera Bioscience completes series-B financing of 30 million dollars, aiming at innovative anti-tumor drugs
WeChat official account
Copyright 2015 Beijing zhikangbo Medical Oncology Research Co., Ltd 京ICP备15041820号